Oxidative renal tubular injuries induced by aminocarboxylate-type iron (III) coordination compounds as candidate renal carcinogens

BioMetals

Volumn 19, Issue 6, 2006, Pages 675-683

  Mizuno, Ryuichiro ^a   Kawabata, Teruyuki ^b   Sutoh, Yuichi ^c   Nishida, Yuzo ^c   Okada, Shigeru ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b OKAYAMA UNIVERSITY OF SCIENCE   (Japan)

^c YAMAGATA UNIVERSITY   (Japan)

Author keywords

oxo dimer; EDTA; IDA; Iron; NTA

Indexed keywords

CARCINOGEN; CHELATING AGENT; FERRIC ETHYLENEDIAMINE N,N' DIACETATE; FERRIC IMINODIACETATE; NITRILOTRIACETATE IRON; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CRYSTALLIZATION; KIDNEY TUBULE DAMAGE; KIDNEY TUBULE NECROSIS; LIPID PEROXIDATION; MALE; NONHUMAN; PH; POLYMERIZATION; RAT; SPECTROPHOTOMETRY; X RAY ANALYSIS;

ANIMALS; CARCINOGENS; DEOXYRIBOSE; EDETIC ACID; ELECTRON SPIN RESONANCE SPECTROSCOPY; FERRIC COMPOUNDS; HYDROGEN-ION CONCENTRATION; IMINO ACIDS; IN SITU NICK-END LABELING; IRON CHELATING AGENTS; KIDNEY DISEASES; KIDNEY TUBULES; MALE; NITRILOTRIACETIC ACID; OXIDATIVE STRESS; RATS; RATS, WISTAR; SPECTROPHOTOMETRY, ULTRAVIOLET; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

RODENTIA;

EID: 33750613030     PISSN: 09660844     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10534-006-9004-4     Document Type: Article

References (33)

1. Awai M, Narasaki M, Yamanoi Y, Seno S. 1979 Induction of diabetes in animals by parenteal administration of ferric nitrilotriacetate. Am J Pathol 95, 663-674.
2. Carl AB, Glenn JR, Ronald LM, Edward IS. 1995 Spectroscopic and electronic structure studies of met-hemerythrin model complexes: A description of the ferric-oxo dimer bond. Inorg Chem 34, 688-717.1.
3. Donald M, Kurtz Jr. 1990 Oxo- and hydroxo-bridged diiron complexes: a chemical perspective on abiological unit. Chem. Rev. 90(4), 585-606.
4. Engelmann MD, Babior RT, Hiatt T, Cheng IF. 2003 Variabirity of the Fenton reaction characteristics of the EDTA, DTPA and citrate complexes of iron. Biometals 16, 519-527.
5. Goodwin JF, Marphy B, Guillemette M. 1966 Direct measurement of serum iron and binding capacity. Clin Chem 12, 47.
6. Halliwell B, Gtteridge JMC, Aruoma OI. 1987 The deoxyribose method: a simple 'test-tube' assay for determination of rate constants for reactions of hydroxyl radicals. Anal Biochem 165, 215-219.
7. Hearth SL, Powell AK. 1992 The trapping of iron hydroxide units by the ligand (hida): Two new hydroxo(oxo)iron clusters containing 19 and 17 iron atoms. Angew Chem 31, 191-193.
8. Hiroyasu M, Ozeki M, Kohda H, Eshizenya M, Tanaka T, Hiai H, Toyokuni S. 2002 Specific allelic loss of p16 (INK4A) tumor suppressor gene after weeks of iron-mediated oxidative damage during rat renal carcinogenesis. Am J Pathol 160, 419-424.
9. Iqbal M, Sharma SD, Mizote A, Fujisawa M, Okada S. 2003 Differential role of hydrogen peroxide and organic hydroperoxides in augmenting ferric nitrilotriacetate (Fe-NTA)-mediated DNA damage: implications for carcinogenesis. Teratog Carcinog Mutagen l 1, 13-21.
10. Kawabata T, Ma Y, Yamador I, Okada S. 1997 Iron-induced apoptosis in mouse renal proximal tubules after an injection of a renal carcinogen, iron-nitrilotriacetate. Carcinogenesis 18, 1389-1389.
11. Liu M, Okada S. 1994 Induction of free radicals and tumors in the kidneys of Wistar rats by ferric ethylenediamine-N,N′-diacetate. Carcinogenesis 15, 2817-2821.
12. Liu M, Okada S, Kawabata T. 1991 Radical-promoting "free" iron level in the serum of rats treated with ferric nitrilotriacetate: comparison with other iron chelate complexes. Acta Med Okayama 45, 401-408.
13. Ma Y, Zhang D, Kawabata T, Kiriu T, Toyokuni S, Uchida K, Okada S. 1997 Copper and iron-induced oxidative damage in non-tumor bearing LEC rats. Pathol Int 47, 203-208.
14. Ma Y, Kawabata T, Hamazaki S, Ogino T, Okada S. 1998 Sex differences in oxidative damage in ddY mouse kidney treated with a renal carcinogen, iron nitrilotriacetate. Carcinogenesis 19, 1983-1988.
15. Mizote A, Hida A, Hosako M, Fujisawa M, Kamekawa M, Okada S. 2002 Effects of phlebotomy on the growth of ferric nitrilotriacetate-induced renal cell carcinoma. Acta Med Okayama 56, 199-204.
16. Nishida Y, Ito S. 1995 Structures and reactivities of several iron (III) complexes in the presence of hydrogen peroxide: relevance to induction of tissue damage caused by iron (III) chelastes in rats. Polyhedron 14, 2301-2308.
17. Nishida Y, Akamatu T. 1991 Preparation of iron (III) complex with nitrilotriacetic acid and origin of its unique reactivity. Chem Lett 1521-1524.
18. Nishida Y. 1989 DNA cleavage by binuclear iron(III)-peroxide adducts. Inorg chem Acta 163, 9-10.
19. Nishida Y. 1999 Structure and function of free iron ion in biological system and their model compounds. Recent Res Devel Pure Applied Chem 3, 103-122.
20. Ohkawa H, Ohnishi N, Yagi K. 1979 Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95, 351-358.
21. Okada S. 2003 Prevention of free-radical mediated tissue damage and carcinogenesis induced by low-molecular-weight iron. Biometals 16, 99-101.
22. Okada S, Fukunaga Y, Hamazaki S, Yamada Y, Toyokuni S. 1991 Sex differences in the localization and severity of ferric nitrilotriacetate-induced lipid peroxidation in the mouse kidney. Acta Pathol Jpn 41, 221-6.
23. Okada S, Minamiyama Y, Hamazaki S, Toyokuni S, Sotomatu A. 1993 Glutathione cycle dependency of ferric nitrilotriacetate-induced lipid peroxidation in mouse proximal renal tubules. Arch Biochem Biophys 301, 138-42.
24. Okada S 1996 Iron-induced tissue damage and cancer: the role of reactive oxygen species-free radicals. Pathol Int 46, 311-32.
25. Que L Jr, True AE. 1990 Dinuclear Iron- and Manganese-Oxo Sites in Biology. Prog Inorg Chem 38, 97-200.
26. Takahashi K, Nishida Y, Maeda Y. 1985 Crystal structure and magnetism of binuclear iron (III) complexes with a linear oxo-bridge. J Chem Soc Dalton Trans 2375-2380.
27. Toyokuni S, Uchida K, Okamoto K. 1994 Formation of 4-hydroxy-2-nonenal- modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate. Proc Nat Acad Sci USA 91, 2616-2620.
28. Toyokuni S, Sagripanti JL 1996 Association between 8-hydroxy-2′- deoxyguanosine formation and DNA strand breaks mediated by copper and iron. Free Radic Biol Med 20, 859-864.
29. Toyokuni S, Sagripanti JL. 1993 DNA single- and doublestrand breaks produced by ferric nitrilotriacetate in relation to renal tubular carcinogenesis. Carcinogenesis 14, 223-227.
30. Toyokuni S. 1996 Iron-induced carcinogenesis: The role of redox regulation. Free Radic Biol Med 20, 553-566.
31. 2/Fe-EDTA cleavage protection studies. J Biol Chem 276(30), 28380-28387.
32. Yuan XM, Brunk UT, Olsson AG 1995 Effects of iron- and hemoglobin-loaded human monocyte-derived macrophages on oxidation and uptake of LDL. Arterioscler Throm Vas Biol 15(9), 1345-1351.
33. Zhang D, Okada S, Yu Y, Zheng P, Ymaguchi R, Kasai H. 1997 Vitamin E inhibits apoptosis, DNA modification, and cancer incidence induced by iron-mediated peroxidation in Wistar rat kidney. Cancer Res 57, 2410-2414.